The effect of patient factors on response outcomes to Botox treatment of spasmodic dysphonia

Journal of Voice

Volumn 12, Issue 4, 1998, Pages 460-466

  Lundy, Donna S ^a,b   Lu, F Ling ^a   Casiano, Roy R ^a   Xue, Jun W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Department of Otolaryngology ^*  (United States)

Author keywords

Botulinum toxin; Spasmodic dysphonia

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGE; AGED; ARTICLE; DEMOGRAPHY; DISEASE SEVERITY; DYSPHONIA; DYSTONIA; FAMILY HISTORY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LARYNX MUSCLE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; SELF REPORT; SEX DIFFERENCE; TREATMENT OUTCOME; VOICE;

EID: 0032441817     PISSN: 08921997     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0892-1997(98)80055-6     Document Type: Article

References (18)

1. Ludlow CL, Nauton RF, Sedory SE, Schulz GM, Hallet M. Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia. Neurology 1988;38:1220-3.
2. Miller RH, Woodson GE, Jankovic J. Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report. Arch Otolaryngol Head Neck Surg 1987;113:603-5.
3. Zwirner P, Murry T, Swenson MD, Woodson GE. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic and videoendoscopic findings. Laryngoscope 1992;4:400-6.
4. Truong DD, Rontal M, Rolnick M, Aronson AE, Mistura K. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia. Laryngoscope 1991;101:630-4.
5. Klap P, Marion MH, Perrin A, Fresnel-Elbaz E, Cohen M. Indications for botulinum toxin in laryngectomy. Revue de Laryngologie Otologie Rhinologie 1993;114:281-7.
6. Loven JO, Brondbo K, Ganes T. Botulinum toxin. A new therapeutic alternative in spastic dysphonia. Tidsskrift for Den Norske Laegeforening 1993;113:841-3.
7. Murry T, Cannito MP, Woodson GE. Spasmodic dysphonia: emotional status and botulinum toxin treatment. Arch Otololarngol Head Neck Surg 1994;120:310-6.
8. Rhew K, Fielder DA, Ludlow CL. Technique for injection of botulinum toxin through the flexible nasolaryngoscope. Otolaryngol Head Neck Surg 1994;111:787-94.
9. Blitzer A, Brin MF, Fahn S, Lovelace RE. Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia). Laryngoscope 1988;98:193-7.
10. Witsell DL, Weissler MC, Donovan MK, Howard JF, Martinkosky SJ. Measurement of laryngeal resistance in the evaluation of botulinum toxin injection for treatment of focal laryngeal dystonia. Laryngoscope 1994;104:8-11.
11. Aronson AE, McCaffrey TV, Litchy WJ, Lipton RJ. Botulinum toxin injection for adductor spastic dysphonia: patient self-ratings of voice and phonatory effort after three successive injections. Laryngoscope 1993;103:683-92.
12. Lees AJ, Turjanski N, Whurr R, Lorch M, Brookes G. Treatment of cervical dystonia, hand spasms and laryngeal dystonia with botulinum toxin. J Neurol 1992;239:1-4.
13. Davis PJ, Boone DR, Carroll RL, Darveniza P, Harrison GA. Adductor spastic dysphonia: heterogeneity of physiologic and phonatory characteristics. Ann Otol Rhinol Laryngol 1988;97:179-85.
14. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. New England J Med 1991;324:1186-94.
15. Maloney AP, Morrison MD. A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia. J Otolaryngol 1994; 23:160-4.
16. Watterson T, McFarlane SC. Adductor and abductor spasmodic dysphonia: different disorders. Am J Speech Lang Pathol 1992;1:19-20.
17. Van Pelt F, Ludlow CL, Smith PJ. Comparison of muscle activation patterns in adductor and abductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 1994;103:192-200.
18. Ford CN, Bless DM, Lowery JD. Indirect laryngoscopic appoach for injection of botulinum toxin in spasmodic dysphonia. Otolaryngol Head Neck Surg 1990;103:752-8.